Description
Non-synthetic, human-derived EDTA plasma that has been processed to remove contaminating cell-free DNA (cfDNA). This base matrix provides a clean, clinically relevant background for the creation of custom controls, calibrators, and validation panels.
Intended Use
Designed for developers of liquid biopsy and non-invasive prenatal testing (NIPT) assays. It allows for the precise spiking of target cfDNA material to create known-positive samples for limit of detection (LOD) studies, linearity assessments, and routine quality control.Designed for developers of liquid biopsy and non-invasive prenatal testing (NIPT) assays. It allows for the precise spiking of target cfDNA material to create known-positive samples for limit of detection (LOD) studies, linearity assessments, and routine quality control.
More Information
Sourced from healthy donors and treated with EDTA as an anticoagulant. The rigorous DNA depletion process ensures minimal background interference, making it an ideal negative control or diluent for sensitive molecular applications.